| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,896 |
15,574 |
$2.17M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,879 |
5,981 |
$915K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,393 |
1,949 |
$351K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,722 |
2,548 |
$316K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,282 |
599 |
$139K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
591 |
586 |
$124K |
| 70450 |
Computed tomography, head or brain; without contrast material |
283 |
223 |
$76K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
423 |
271 |
$71K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,009 |
1,906 |
$71K |
| 80053 |
Comprehensive metabolic panel |
7,960 |
6,872 |
$70K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
263 |
163 |
$64K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
840 |
285 |
$62K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
143 |
85 |
$47K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,791 |
1,628 |
$36K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
109 |
74 |
$29K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,288 |
3,571 |
$29K |
| 80061 |
Lipid panel |
1,483 |
1,389 |
$28K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,043 |
2,611 |
$26K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,200 |
9,564 |
$24K |
| 71046 |
Radiologic examination, chest; 2 views |
1,289 |
1,154 |
$21K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
541 |
170 |
$19K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
860 |
812 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
10,388 |
8,881 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,259 |
2,056 |
$15K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
241 |
154 |
$13K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
66 |
64 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
759 |
677 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
498 |
447 |
$8K |
| 83735 |
|
1,072 |
949 |
$8K |
| 84484 |
|
2,109 |
1,459 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
354 |
285 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,253 |
1,064 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
16 |
15 |
$5K |
| 84439 |
|
151 |
133 |
$4K |
| 73110 |
|
79 |
58 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
315 |
314 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
1,857 |
1,608 |
$4K |
| 80076 |
|
353 |
281 |
$4K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
25 |
13 |
$3K |
| 80320 |
|
342 |
256 |
$3K |
| 97162 |
|
83 |
61 |
$3K |
| 73610 |
|
71 |
56 |
$3K |
| 73564 |
|
65 |
50 |
$3K |
| 85027 |
|
466 |
386 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,589 |
1,202 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
47 |
40 |
$2K |
| 73630 |
|
121 |
108 |
$2K |
| 74018 |
|
61 |
54 |
$2K |
| 83605 |
|
527 |
383 |
$2K |
| 81001 |
|
3,340 |
2,913 |
$2K |
| 73130 |
|
35 |
26 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,255 |
2,618 |
$1K |
| 83690 |
|
1,306 |
1,048 |
$1K |
| 85610 |
|
828 |
604 |
$1K |
| 87186 |
|
231 |
176 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,117 |
893 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,662 |
1,272 |
$781.44 |
| 92523 |
|
12 |
12 |
$777.98 |
| 82947 |
|
525 |
314 |
$754.35 |
| 84703 |
|
824 |
658 |
$672.64 |
| 86140 |
|
30 |
26 |
$666.06 |
| 85379 |
|
344 |
263 |
$569.91 |
| 72110 |
|
15 |
14 |
$543.20 |
| 81003 |
|
579 |
474 |
$428.62 |
| 85652 |
|
64 |
51 |
$409.46 |
| 83540 |
|
33 |
28 |
$401.01 |
| 94664 |
|
157 |
118 |
$314.14 |
| 82607 |
|
12 |
12 |
$304.93 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$238.61 |
| 83550 |
|
15 |
15 |
$211.07 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$194.16 |
| 81025 |
|
392 |
310 |
$108.31 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
288 |
231 |
$76.05 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
53 |
50 |
$70.66 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,643 |
1,283 |
$50.80 |
| 83880 |
|
16 |
12 |
$45.51 |
| 87807 |
|
47 |
40 |
$37.59 |
| 80143 |
|
18 |
13 |
$36.28 |
| 80179 |
|
15 |
12 |
$18.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
592 |
472 |
$14.84 |
| 87077 |
|
16 |
12 |
$14.52 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,253 |
897 |
$9.68 |
| J2704 |
Injection, propofol, 10 mg |
369 |
135 |
$9.55 |
| 87040 |
|
25 |
12 |
$6.57 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
170 |
115 |
$5.96 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
26 |
24 |
$1.85 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
55 |
42 |
$0.63 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
626 |
450 |
$0.00 |
| 80306 |
|
12 |
12 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
35 |
33 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
47 |
40 |
$0.00 |
| 85730 |
|
28 |
24 |
$0.00 |